D-K6L9
D-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. D-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance [1].
Product Specifications
CAS Number
426264-61-1
UNSPSC
12352209
Target
Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/d-k6l9.html
Solubility
10 mM in DMSO
Smiles
CC(C)C[C@@H](C(N)=O)NC([C@H](CC(C)C)NC([C@@H](CCCCN)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CCCCN)NC([C@@H](CCCCN)NC([C@@H](CC(C)C)NC([C@H](CC(C)C)NC([C@@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CC(C)C)NC([C@@H](CC(C)C)NC([C@H](CCCCN)NC([C@@H](N)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C90H174N22O15
Molecular Weight
1804.48
References & Citations
[1]Ben Hur D, et al. Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients. J Med Chem. 2022;65 (13) :9050-9062.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
32-10397-50 50 µg
Recombinant Human Kinetochore scaffold 1/KNL1 (C-His)
Sign In for Pricing
View Details 